Ronald Harold Wilfred Cooper
Director · C4 Therapeutics, Inc.
- 2024
- Jun 26, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ronald Harold Wilfred Cooper files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Leonard Reyno - $22K in CCCC purchases and sales in the last 12 months
- William Grossman - $10K in ENGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ronald Harold Wilfred Cooper?
Ronald Harold Wilfred Cooper is a corporate insider, tracked as Director of C4 Therapeutics, Inc. (CCCC). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ronald Harold Wilfred Cooper last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 4 filings going back to 2024.
Has Ronald Harold Wilfred Cooper been buying or selling stock?
Recorded transactions: 1 open-market purchase ($57K) and 0 open-market sales across all tracked filings.
